Evidence map›Paper›PMID 41100669›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2025

Parkinsonism disrupts the balance between excitatory and inhibitory activity within the primary motor cortex during movement.

Biswaranjan Mohanty, Zheshan Guo, Luke A Johnson, Jing Wang, Jerrold L Vitek

Abstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Parkinsonism disrupts the balance between excitatory and inhibitory activity within the primary motor cortex during movement.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Biswaranjan Mohanty *Department of Neurology, University of Minnesota, Minneapolis, MN 55455.ORCID 0000-0002-3924-039X
Zheshan Guo *Department of Neurology, University of Minnesota, Minneapolis, MN 55455.ORCID 0000-0001-9707-4185
Luke A JohnsonDepartment of Neurology, University of Minnesota, Minneapolis, MN 55455.ORCID 0000-0002-9069-1436
Jing WangDepartment of Neurology, University of Minnesota, Minneapolis, MN 55455.
Jerrold L VitekDepartment of Neurology, University of Minnesota, Minneapolis, MN 55455.ORCID 0000-0002-2308-6535

Funding

Deep Brain Stimulation in the Parkinsonian MonkeyR01NS037019 · NINDS · UNIVERSITY OF MINNESOTA · PI Jerrold L Vitek · 1999 to 2026
$14.5M
Understanding Circuit Dynamics in Parkinson's Disease using Real-Time Neural ControlP50NS123109 · NINDS · UNIVERSITY OF MINNESOTA · PI AMAN, JOSHUA E · 2021 to 2025
$11.3M
Neurophysiological Mechanisms Underlying Parkinsonian Motor SignsR01NS058945 · NINDS · UNIVERSITY OF MINNESOTA · PI LUKE Aaron JOHNSON, Jerrold L Vitek · 2008 to 2026
$9.6M
The Effects of Parkinsonism and Deep Brain Stimulation on Basal Ganglia-Thalamocortical Circuitry During Sleep-Wake BehaviorR01NS110613 · NINDS · UNIVERSITY OF MINNESOTA · PI LUKE Aaron JOHNSON · 2019 to 2026
$4.7M
Neuronal Activity in MC and SMA during STN and GPi DBS in the Parkinsonian MonkeyR37NS077657 · NINDS · UNIVERSITY OF MINNESOTA · PI VITEK, JERROLD L · 2018 to 2024
$4.4M
Optimizing coordinated reset deep brain stimulation for Parkinson's diseaseR01NS117822 · NINDS · UNIVERSITY OF MINNESOTA · PI WANG, JING · 2020 to 2024
$3.0M
Neuronal Activity in MC and SMA during STN and GPi DBS in the Parkinsonian MonkeyR01NS077657 · NINDS · UNIVERSITY OF MINNESOTA · PI VITEK, JERROLD L · 2012 to 2016
$2.6M
Sleep-specific DBS therapy in Parkinson's diseaseR01NS131371 · NINDS · UNIVERSITY OF MINNESOTA · PI LUKE Aaron JOHNSON · 2023 to 2026
$2.4M
HHS | NIH | National Institute of Neurological Disorders and Stroke (NINDS) P50-NS123109HHS | NIH | National Institute of Neurological Disorders and Stroke (NINDS) R01-NS037019HHS | NIH | National Institute of Neurological Disorders and Stroke (NINDS) R01-NS058945HHS | NIH | National Institute of Neurological Disorders and Stroke (NINDS) R01-NS110613HHS | NIH | National Institute of Neurological Disorders and Stroke (NINDS) R01-NS131371HHS | NIH | National Institute of Neurological Disorders and Stroke (NINDS) R37- NS077657NINDS NIH HHS P50 NS123109NINDS NIH HHS R01 NS037019NINDS NIH HHS R01 NS058945NINDS NIH HHS R01 NS077657NINDS NIH HHS R01 NS110613NINDS NIH HHS R01 NS117822NINDS NIH HHS R01 NS131371NINDS NIH HHS R37 NS077657
6 · The paper itself

Abstract

Parkinson's disease (PD) has been associated with alterations in neuronal activity in the basal ganglia-thalamocortical (BGTC) network. Previous studies have suggested that cortical disinhibition is a feature of PD, but there has been little direct evidence of the changes in cortical neuronal spiking activity to support this hypothesis. To test the hypothesis that activity in the motor cortex is enhanced in PD, we investigated the effects of parkinsonism on movement-related neuronal activity in the primary motor cortex (M1). Microelectrode arrays were chronically implanted in M1 of two nonhuman primates and populations of cells were collected before and after the induction of parkinsonism using the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. In both animals, we found that during the reaching task in the parkinsonian state, the proportion of M1 neurons that were activated (excited) during movement were increased, while those that were suppressed (inhibited) decreased. These data support the concept that dopaminergic loss in parkinsonism promotes a loss of inhibition in the motor cortex, leading to overactivity in M1 and a disruption in spatial-temporal processing of information within the BGTC circuit that contributes to the motor dysfunction observed in PD.

Indexed as

Motor CortexNeural InhibitionParkinsonian Disorders1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridineAction PotentialsAnimalsMacaca mulattaMaleMovementNeurons1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridinemotor cortexMPTPParkinson’s diseasereaching movementsingle unit

Identifiers

PMID41100669
PMCPMC12557514

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.